The safety of drugs for inflammatory bowel disease during pregnancy and breastfeeding: the DUMBO registry study protocol of GETECCU

BACKGROUND: Active disease during conception and pregnancy in women with inflammatory bowel disease (IBD) increases the risk of pregnancy complications and adverse neonatal outcomes. The use of IBD treatments during pregnancy should be weighed against their adverse effects on the neonate, but longer...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaparro, María, Donday, María G., Abad-Santos, Francisco, Martín de Carpi, Francisco Javier, Maciá-Martínez, Miguel Ángel, Montero, Dolores, Acosta, Diana, Brenes, Yanire, Gisbert, Javier P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182220/
https://www.ncbi.nlm.nih.gov/pubmed/34158835
http://dx.doi.org/10.1177/17562848211018097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182220/
https://www.ncbi.nlm.nih.gov/pubmed/34158835
http://dx.doi.org/10.1177/17562848211018097

Ejemplares similares